Protection and antibody responses in different strains of mouse immunized with plasmid DNAs encoding influenza virus haemagglutinin, neuraminidase and nucleoprotein

被引:75
作者
Chen, Z
Yoshikawa, T
Kadowaki, S
Hagiwara, Y
Matsuo, K
Asanuma, H
Aizawa, C
Kurata, T
Tamura, S
机构
[1] Natl Inst Infect Dis, Dept Pathol, Shinjuku Ku, Tokyo 1628640, Japan
[2] Kitasato Inst, Biol Res Ctr, Kitamoto, Saitama 3640026, Japan
关键词
D O I
10.1099/0022-1317-80-10-2559
中图分类号
Q81 [生物工程学(生物技术)]; Q93 [微生物学];
学科分类号
071005 ; 0836 ; 090102 ; 100705 ;
摘要
Protection against influenza virus infection and antibody responses in mice vaccinated with plasmid DNAs encoding haemagglutinin (HA), neuraminidase (NA) and nucleoprotein (NP) were compared among BALB/c (H-2(d)), B10 (H-2(b)) and C3H (H-2(k)) mice. Mice were inoculated with each DNA construct twice, 3 weeks apart, at a dose of 1 mu g per mouse by particle-mediated DNA transfer (gene gun) to the epidermis. They were challenged with a lethal dose of the homologous virus 7 days after the second vaccination, NA-DNA provided significant protection in all strains of mouse, whereas HA-DNA afforded significant protection only in BALB/c mice. The serum antibody titres against NA or HA molecules in BALB/c, C3H and B10 mice were high, intermediate and low, respectively. NP-DNA failed to provide protection in any strain of mouse, and elicited low titres of anti-NP antibodies, These results suggest that NA-DNA can be used as a vaccine component to provide effective protection against influenza virus infection in various strains of mouse.
引用
收藏
页码:2559 / 2564
页数:6
相关论文
共 38 条
[1]  
ADA GL, 1986, CURR TOP MICROBIOL, V128, P1
[2]  
BRODSKY FM, 1991, ANNU REV IMMUNOL, V9, P707
[3]   Comparison of the ability of viral protein-expressing plasmid DNAs to protect against influenza [J].
Chen, Z ;
Sahashi, Y ;
Matsuo, K ;
Asanuma, H ;
Takahashi, H ;
Iwasaki, T ;
Suzuki, Y ;
Aizawa, C ;
Kurata, T ;
Tamura, S .
VACCINE, 1998, 16 (16) :1544-1549
[4]   Enhanced protection against a lethal influenza virus challenge by immunization with both hemagglutinin- and neuraminidase-expressing DNAs [J].
Chen, Z ;
Matsuo, K ;
Asanuma, H ;
Takahashi, H ;
Iwasaki, T ;
Suzuki, Y ;
Aizawa, C ;
Kurata, T ;
Tamura, S .
VACCINE, 1999, 17 (7-8) :653-659
[5]   INDUCTION OF PARTIAL IMMUNITY TO INFLUENZA BY A NEURAMINIDASE-SPECIFIC VACCINE [J].
COUCH, RB ;
KASEL, JA ;
GERIN, JL ;
SCHULMAN, JL ;
KILBOURNE, ED .
JOURNAL OF INFECTIOUS DISEASES, 1974, 129 (04) :411-420
[6]   Recombinant neuraminidase vaccine protects against lethal influenza [J].
Deroo, T ;
Jou, WM ;
Fiers, W .
VACCINE, 1996, 14 (06) :561-569
[7]   DNA vaccines [J].
Donnelly, JJ ;
Ulmer, JB ;
Shiver, JW ;
Liu, MA .
ANNUAL REVIEW OF IMMUNOLOGY, 1997, 15 :617-648
[8]   PRECLINICAL EFFICACY OF A PROTOTYPE DNA VACCINE - ENHANCED PROTECTION AGAINST ANTIGENIC DRIFT IN INFLUENZA-VIRUS [J].
DONNELLY, JJ ;
FRIEDMAN, A ;
MARTINEZ, D ;
MONTGOMERY, DL ;
SHIVER, JW ;
MOTZEL, SL ;
ULMER, JB ;
LIU, MA .
NATURE MEDICINE, 1995, 1 (06) :583-587
[9]  
Feltquate DM, 1997, J IMMUNOL, V158, P2278
[10]   Protective cellular immunity: Cytotoxic T-lymphocyte responses against dominant and recessive epitopes of influenza virus nucleoprotein induced by DNA immunization [J].
Fu, TM ;
Friedman, A ;
Ulmer, JB ;
Liu, MA ;
Donnelly, JJ .
JOURNAL OF VIROLOGY, 1997, 71 (04) :2715-2721